Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. MU
6. USO
7. APGE
8. ABBV
9. NAVN
10. DFTX

Go back to Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform
Johnson & Johnson (NYSE: JNJ) Delayed: 231.29 --0 (-0%)
Previous Close $231.29    52 Week High $126.07 
Open $231.29    52 Week Low $94.28 
Day High $231.29    P/E 48.09 
Day Low $231.29    EPS $4.81 
Volume 4,295